- Title
- Increased duration of time without transfusion reliance with imetelstat versus placebo in the phase 3 IMerge trial
- Creators
- Mikkael A. Sekeres - University of MiamiValeria Santini - University of FlorenceAmer M. Zeidan - Yale Cancer CenterUwe Platzbecker - National Center for Tumor DiseasesRami S. Komrokji - Moffitt Cancer CenterMaría Díez-Campelo - Universidad de SalamancaPierre Fenaux - Hôpital Saint-LouisMichael R. Savona - Vanderbilt University Medical CenterYazan F. Madanat - Southwestern Medical CenterDavid Valcárcel - Vall d'Hebron Hospital UniversitariAntoine Regnault - Centre Technique Cuir Chaussure Maroquinerie (France)Flora Mazerolle - Centre Technique Cuir Chaussure Maroquinerie (France)Libo Sun - Geron (United States)Ying Wan - Geron (United States)Tymara Berry - Geron (United States)Faye Feller - Geron (United States)Shyamala Navada - Geron (United States)Esther Natalie Oliva - London North West Healthcare NHS Trust
- Publication Details
- Blood neoplasia, p.100216
- Publisher
- Elsevier Inc
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991033027770502976
Journal article
Increased duration of time without transfusion reliance with imetelstat versus placebo in the phase 3 IMerge trial
Blood neoplasia, p.100216
2026-03
Metrics
1 Record Views